Lecture 7: Catecholamines 1 Flashcards

1
Q

Explain Catecholamine Synthesis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain Catecholamine Release

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain Catecholamine Inactivation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the Organization of the Dopaminergic System

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the Function of the Dopaminergic System

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the processes involved in catecholamine synthesis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the processes involved in catecholamine storage

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the processes involved in catecholamine release.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain how catecholamines are inactivated using reuptake.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain how catecholamines are inactivated using metabolism.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List and explain the clinical uses of drugs that act on catecholamine metabolism.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List and explain the clinical uses of drugs that act on catecholamine reuptake.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the major ascending dopaminergic pathways that originate in the midbrain

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Identify the locations of the cell bodies and the projection areas of each dopaminergic pathway.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the role of DA in behavioral regulation, using initiation and control of voluntary movement

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the role of DA in behavioral regulation using responses to rewarding stimuli

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain the role of DA in behavioral regulation using cognitive functioning.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the members of the family of DA receptors

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the family of DA receptors’ various subtypes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the family of DA receptors’ signaling mechanisms

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the family of DA receptors’ roles as postsynaptic receptors

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the family of DA receptors’ roles as autoreceptors.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the behavioral effects of DA receptor agonists

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the behavioral effects of DA receptor antagonists

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the physiological effects of DA receptor agonists

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe the physiological effects of DA receptor antagonists

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe DA receptor clinical applications

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are catecholamines?

A

Catecholamines are monamines: a catechol + amine group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the different types of catecholamines?

A
  1. Dopamine (DA)
  2. Norepinephrine (NE)
  3. Epinephrine (EPI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the adjective forms of the catecholamines?

A

dopaminergic, noradrenergic, and adrenergic

31
Q

What secretes from the adrenal medulla and what do they act as?

A

Adrenal medulla secretes EPI and NE into the bloodstream where they act as hormones.

32
Q

How are catecholamines synthesized?

A

By a multistep pathway in which tyrosine hydroxylase catalyzes the rate-limiting step

33
Q

What are catecholamines synthesized from?

34
Q

What is Tyrosine hydroxylase (TH)

A

the rate-limiting enzyme

35
Q

What factor affects TH activity with negative feedback?

A

DA and NE levels in the nerve terminal

36
Q

What factor stimulates TH activity?

A

Cell firing stimulates TH activity through phosphorylation of the enzyme by protein kinases

37
Q

How is tyrosine obtained?

A

Tyrosine is obtained from dietary protein, transported from blood to brain

38
Q

How can catecholamine synthesis be increased?

A

By administering precursors such as tyrosine or l-DOPA

39
Q

What is used to treat Parkinson’s disease?

40
Q

What is each step of synthesis dependent on?

A

specific enzymes – dependent on neuron

EX: If neurons use DA as NT, only contain TH and AAAD
If neurons need NE, also possess DBH

41
Q

What do drugs that reduce synthesis do?

A

inhibit one of the enzymes

42
Q

What is the drug that blocks TH?

A

α-methyl-para-tyrosine (AMPT)

43
Q

What are the steps in synthesis called?

A

synthetic pathways

44
Q

What do synthetic pathways do?

A

provides a mechanism for regulating the amount of transmitter available for release

45
Q

What opportunity is possible with synthetic pathways?

A

to intervene with drugs that alter transmitter synthesis in specific ways.

46
Q

What catalyzes conversion of dopamine to norepinephrine?

A

dopamine β-hydroxylase (DBH)

47
Q

What catalyzes conversion of DOPA to dopamine?

A

Aromatic amino acid decarboxylase (AADC)

48
Q

What is catecholamine storage and release regulated by?

A

vesicular uptake
autoreceptor activity
cell firing rate

49
Q

What are catecholamines loaded into synaptic vesicles by?

A

vesicular monoamine transporters (VMAT)

50
Q

What can VMAT be blocked by?

A

reserpine (snake root)

51
Q

What is snake root and what symptoms can it cause?

A

an irreversible inhibitor; (reduces the amount of NT at the terminal) causes sedation and depressive symptoms

52
Q

What are reversible inhibitors of VMAT used for?

A

To reduce uncontrolled movements in Huntington’s disease and tardive dyskinesia.

53
Q

Where is VMAT1 found?

A

adrenal medulla

54
Q

Where is VMAT2?

A

present in the brain

55
Q

What do VMAT1 and VMAT2 have in common?

A

Both can be blocked by reserpine.

56
Q

What are some reversible VMAT2 inhibitors?

A

tetrabenazine (trade name Xenazine), deutetrabenazine (Austedo), and valbenazine (Ingrezza)

57
Q

What makes TH the rate limiting enzyme?

A

Tyrosine to DOPA by TH occurs slower

58
Q

What stimulates TH activity?

A

Neuronal firing

59
Q

What determines the overall rate of DA or NE formation?

A

Tyrosine Hydroxylase

60
Q

What regulates the activity in the neurons of the dopaminergic system?

A

the amount of DA/NE present at the terminal, negative feedback when high.

61
Q

What is done to TH by second messengers, what are they, and what do they do?

A

TH can be phosphorylated by a number of secondary messengers (PKA, PKC, CaMKII). Generally increases the enzyme activity.

62
Q

How can you increase the formation of TH?

A

by increasing precursors such as tyrosine and L-DOPA.

63
Q

What is Tyrosine administration used for?

A

Enhancing cognitive functions e.g. memory

64
Q

What is L-DOPA the primary therapeutic agent for?

A

treating Parkinsons

65
Q

What does a typical dopaminergic neuron’s membrane possess?

A

Autoreceptors. When these receptors are stimulated, they inhibit sub¬sequent DA release by the cell.

66
Q

What are some psychostimulants and what do they do?

A

Psychostimulants amphetamine and methamphetamine cause release of catecholamines without nerve firing. Lab animals show increased activity.

67
Q

What type of behaviors occur with high doses of psychostimulants and what are they?

A

Stereotyped behaviors include intense sniffing, repetitive head and limb movements, and licking and biting.

68
Q

What are human side effects of psychostimulants?

A

In humans, drug effects include increased alertness, high energy levels, euphoria, insomnia

69
Q

What release is impacted by autoreceptors and how?

A

DA release is inhibited by autoreceptors

70
Q

What also influences DA release?

A

Neuron firing pattern

71
Q

What is the first way neuron firing impacts DA release?

A

Single-spiking mode: action potentials appear at irregular intervals (tonic release)

72
Q

What is the second way neuron firing impacts DA release?

A

Burst mode: trains of 2–20 spikes at higher frequency (phasic release); transmitter release occurring faster than it can be cleared and/or metabolized.